Skip to content
10-Q

Quarterly Report

Bio-AMD Inc.

0001185185-15-001235

← back to feed
Filed
May 14, 2015 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted Q1 2015 · Mar 31, 2015 44.71M sh
Shares Diluted Q1 2015 · Mar 31, 2014 44.53M sh
Capex Q1 2015 · Mar 31, 2015 $0
Capex Q1 2015 · Mar 31, 2014 $0
Stockholders Equity Q1 2015 · Mar 31, 2015 $635.28K
Stockholders Equity Q1 2015 · Dec 31, 2014 $833.4K
Current Liabilities Q1 2015 · Mar 31, 2015 $1.11M
Current Liabilities Q1 2015 · Dec 31, 2014 $50.31K
Total Liabilities Q1 2015 · Mar 31, 2015 $1.11M
Total Liabilities Q1 2015 · Dec 31, 2014 $50.31K
Current Assets Q1 2015 · Mar 31, 2015 $1.61M
Current Assets Q1 2015 · Dec 31, 2014 $750.76K
Eps Diluted Q1 2015 · Mar 31, 2015 $0.00
Eps Diluted Q1 2015 · Mar 31, 2014 −$0.01
Eps Basic Q1 2015 · Mar 31, 2015 $0.00
Eps Basic Q1 2015 · Mar 31, 2014 −$0.01
Operating Income Q1 2015 · Mar 31, 2015 −$223.63K
Operating Income Q1 2015 · Mar 31, 2014 −$317.33K
Revenue Q1 2015 · Mar 31, 2015 $0
Revenue Q1 2015 · Mar 31, 2014 $0
Total Assets Q1 2015 · Dec 31, 2014 $883.71K
Total Assets Q1 2015 · Mar 31, 2014 $1.81M
Shares Outstanding restated Q1 2015 · May 8, 2014 44.83M sh
Cash And Equivalents Q1 2015 · Mar 31, 2014 $1.7M
Cash And Equivalents Q1 2015 · Dec 31, 2013 $1.92M
Sga Expense Q1 2015 · Mar 31, 2014 $317.33K
Net Income Q1 2015 · Mar 31, 2014 −$315.77K